SK285869B6 - Zlúčeniny na liečbu kožných ochorení, ich použitie a farmaceutické prípravky s ich obsahom - Google Patents
Zlúčeniny na liečbu kožných ochorení, ich použitie a farmaceutické prípravky s ich obsahom Download PDFInfo
- Publication number
- SK285869B6 SK285869B6 SK951-2001A SK9512001A SK285869B6 SK 285869 B6 SK285869 B6 SK 285869B6 SK 9512001 A SK9512001 A SK 9512001A SK 285869 B6 SK285869 B6 SK 285869B6
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- formula
- hydrogen
- methylnicotinic acid
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL330768A PL190755B1 (pl) | 1999-01-07 | 1999-01-07 | Preparat do leczenia i profilaktyki chorób skóry |
| PCT/IB2000/000019 WO2000040559A1 (en) | 1999-01-07 | 2000-01-07 | Compositions for the treatment of skin diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK9512001A3 SK9512001A3 (en) | 2001-12-03 |
| SK285869B6 true SK285869B6 (sk) | 2007-10-04 |
Family
ID=20073560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK951-2001A SK285869B6 (sk) | 1999-01-07 | 2000-01-07 | Zlúčeniny na liečbu kožných ochorení, ich použitie a farmaceutické prípravky s ich obsahom |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1147086B9 (cs) |
| AT (1) | ATE292117T1 (cs) |
| AU (1) | AU1792700A (cs) |
| CZ (1) | CZ299662B6 (cs) |
| DE (1) | DE60019086T2 (cs) |
| ES (1) | ES2238985T3 (cs) |
| HU (1) | HU225475B1 (cs) |
| PL (2) | PL190755B1 (cs) |
| RU (1) | RU2199319C1 (cs) |
| SK (1) | SK285869B6 (cs) |
| UA (1) | UA73491C2 (cs) |
| WO (1) | WO2000040559A1 (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ303214B6 (cs) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití |
| PL364348A1 (en) | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Application of quaternary pyridine salts as vessel protection agent |
| DE102004013798A1 (de) * | 2004-03-20 | 2005-10-06 | Wella Aktiengesellschaft | Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material |
| CA2614885C (en) | 2005-07-11 | 2015-03-17 | Pharmena North America Inc. | Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities |
| WO2007065281A1 (en) * | 2005-12-09 | 2007-06-14 | Cerecon Ag | Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| US20070259861A1 (en) * | 2006-03-08 | 2007-11-08 | Pharmena North America Inc. | Combination therapy with non-selective COX inhibitors to prevent COX-related gastric injuries |
| US20080112968A1 (en) * | 2006-10-11 | 2008-05-15 | Dermena | Nicotinamide compositions for treatment of skin diseases and disorders |
| EP2079471A2 (en) * | 2006-10-18 | 2009-07-22 | Dermena | Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders |
| RU2470645C2 (ru) * | 2007-09-10 | 2012-12-27 | Гленмарк Фармасьютикалс Лимитед | Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида |
| WO2009047291A2 (en) | 2007-10-12 | 2009-04-16 | Politechnika Lódzka | Use of quaternary pyridinium salts for inhibiting cancer metastases |
| TWI432188B (zh) * | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類 |
| WO2018015862A1 (en) | 2016-07-18 | 2018-01-25 | Pharmena S.A. | 1-methylnicotinamide salts for use in raising the blood levels of adiponectin |
| CA3146376A1 (en) | 2019-07-12 | 2021-01-21 | Unilever Global Ip Limited | Bioenergetic combinations and methods of using same |
| WO2021205341A1 (en) | 2020-04-07 | 2021-10-14 | Pharmena S.A. | 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
| US4067975A (en) * | 1975-08-04 | 1978-01-10 | Yu Ruey J | Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide |
| US4505896A (en) * | 1979-04-19 | 1985-03-19 | Elorac, Ltd. | Method of treating acne vulgaris and composition |
| US4578394A (en) * | 1984-12-10 | 1986-03-25 | Hoechst-Roussel Pharmaceuticals Incorporated | Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines |
| DE3603601C3 (de) * | 1986-02-06 | 1999-12-23 | Jutta Mai | Verwendung eines Bockshornkleesamenextraktes |
| US4786647A (en) * | 1986-06-30 | 1988-11-22 | University Of Florida | Method for eliciting anxiolysis |
| US5372911A (en) * | 1991-06-13 | 1994-12-13 | Dainippon Ink And Chemicals, Inc. | Process of forming super high-contrast negative images and silver halide photographic material and developer being used therefor |
| WO1998052927A1 (en) * | 1997-05-19 | 1998-11-26 | Rosemarie Scivoletto | Composition for treating skin conditions |
-
1999
- 1999-01-07 PL PL330768A patent/PL190755B1/pl unknown
-
2000
- 2000-01-07 EP EP00900030A patent/EP1147086B9/en not_active Expired - Lifetime
- 2000-01-07 CZ CZ20012450A patent/CZ299662B6/cs not_active IP Right Cessation
- 2000-01-07 PL PL396696A patent/PL396696A1/pl unknown
- 2000-01-07 SK SK951-2001A patent/SK285869B6/sk not_active IP Right Cessation
- 2000-01-07 AU AU17927/00A patent/AU1792700A/en not_active Abandoned
- 2000-01-07 HU HU0104963A patent/HU225475B1/hu unknown
- 2000-01-07 WO PCT/IB2000/000019 patent/WO2000040559A1/en active IP Right Grant
- 2000-01-07 DE DE60019086T patent/DE60019086T2/de not_active Expired - Lifetime
- 2000-01-07 RU RU2001121650/14A patent/RU2199319C1/ru active
- 2000-01-07 ES ES00900030T patent/ES2238985T3/es not_active Expired - Lifetime
- 2000-01-07 AT AT00900030T patent/ATE292117T1/de active
- 2000-07-01 UA UA2001075379A patent/UA73491C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK9512001A3 (en) | 2001-12-03 |
| PL190755B1 (pl) | 2006-01-31 |
| DE60019086D1 (de) | 2005-05-04 |
| HUP0104963A3 (en) | 2002-11-28 |
| EP1147086A1 (en) | 2001-10-24 |
| PL330768A1 (en) | 2000-07-17 |
| ES2238985T9 (es) | 2011-03-24 |
| ATE292117T1 (de) | 2005-04-15 |
| EP1147086B1 (en) | 2005-03-30 |
| RU2199319C1 (ru) | 2003-02-27 |
| EP1147086B9 (en) | 2010-09-22 |
| HUP0104963A2 (hu) | 2002-04-29 |
| WO2000040559A1 (en) | 2000-07-13 |
| CZ20012450A3 (cs) | 2002-10-16 |
| CZ299662B6 (cs) | 2008-10-08 |
| UA73491C2 (uk) | 2005-08-15 |
| HU225475B1 (en) | 2006-12-28 |
| PL396696A1 (pl) | 2012-01-16 |
| RU2001121650A (ru) | 2004-02-27 |
| DE60019086T2 (de) | 2006-02-02 |
| ES2238985T3 (es) | 2005-09-16 |
| AU1792700A (en) | 2000-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0391033B1 (en) | Retinal, derivatives and their therapeutic use | |
| US6437002B1 (en) | Agent for preventing and treating skin diseases | |
| US4141977A (en) | Treatment of psoriasis with 6-substituted nicotinamides, 2-substituted pyrazinamides and closely related compounds | |
| SK285869B6 (sk) | Zlúčeniny na liečbu kožných ochorení, ich použitie a farmaceutické prípravky s ich obsahom | |
| PL185294B1 (pl) | Przeciwświądowe kompozycje kosmetyczne i/lub farmaceutyczne, ich zastosowanie do wytwarzania leków i sposób ich wytwarzania | |
| KR20150025286A (ko) | 피토스핑고신-1-포스페이트 또는 그 유도체를 포함하는 아토피 또는 피부상처 치료 또는 예방용 조성물 | |
| JPS62246515A (ja) | タモキシフエン又はその製薬上認容性塩を含有する乾癬の治療剤 | |
| GB2181051A (en) | Anti-acne compositions | |
| US4055662A (en) | Antimicrobial composition containing 10-undecensic acid isopropylic ester | |
| GB2056279A (en) | Dermatological compositions containing alkaloids | |
| US4764361A (en) | Pharmaceutical compositions | |
| JP6255154B2 (ja) | 皮膚外用剤 | |
| JPH07316022A (ja) | 育毛剤 | |
| US6485714B1 (en) | Use of salicylic acid for regulating hyperpigmented spots | |
| EP1963270B1 (en) | Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents | |
| KR100202058B1 (ko) | 혼합미백제 조성물 | |
| PL211459B1 (pl) | Zastosowanie czwartorzędowych soli pirydyniowych oraz preparat farmaceutyczny zawierający czwartorzędowe sole pirydyniowe | |
| KR20160037530A (ko) | 피페리딘-2,5-디온의 제조방법 및 이를 포함하는 약학적 조성물 | |
| JP2001163783A (ja) | 皮膚疾患治療用外用剤 | |
| JPH10245393A (ja) | トリテルペン類を含有する組成物 | |
| JP2000169497A (ja) | 新規なトリテルペン類およびこれを含有する組成物 | |
| CN116509831A (zh) | 含有藏红花酸或其可药用盐的外用制剂的用途 | |
| JP3538367B2 (ja) | 皮膚組織障害治療・予防・改善用外用剤 | |
| CN110840878A (zh) | 一种用于治疗银屑病的化合物及其制备方法 | |
| JPS6344511A (ja) | 養毛剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Patent expired |
Expiry date: 20200107 |